Impax Laboratories Confirms Patent Challenge Relating To WELCHOL(R) 625 Mg Tablets

Links shared publicly online about this topic.

  • 1,447
    total visits

Impax Laboratories Confirms Patent Challenge Relating To WELCHOL(R) 625 Mg Tablets

medicalnewstoday.com —

Impax Laboratories, Inc. (NASDAQ:IPXL) confirms that it has initiated a challenge of patents listed by Daiichi Sankyo, Inc. in connection with its WELCHOL® (Colesevelam HCl) tablets, 625 mg.

View full resource at medicalnewstoday.com

Tags: Daiichi Sankyo

  • Share

Most Recently Shared on January 18, 2010 at 5:16 pm By:

mnt_cholesterol MNT Cholesterol News

Impax Laboratories Confirms Patent Challenge Relating To WELCHOL(R) 625 Mg Tablets http://mnt.to/3wsP

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

medical_tweets medical_tweets

Advertisement